Literature DB >> 6092440

Vesiculobullous lesions caused by cytomegalovirus infection in an immunocompromised adult.

J Bhawan, S Gellis, A Ucci, T W Chang.   

Abstract

Skin involvement in cytomegalovirus (CMV) infection is very rare. Reported cutaneous manifestations are nonspecific and include petechial, purpuric, and morbilliform rashes. We describe an immunocompromised patient who developed a vesiculobullous eruption. A simple Tzanck preparation from the base of a blister revealed multinucleate giant cells suggestive of a viral infection. Subsequent viral cultures and electron microscopic studies confirmed the diagnosis of CMV infection. Consideration of this infection should be included in the differential diagnosis of multinucleate giant cells seen on Tzanck preparations of cutaneous vesicles.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6092440     DOI: 10.1016/s0190-9622(84)70234-9

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  5 in total

Review 1.  Pulmonary infections in immunocompromised children.

Authors:  V P Choudhry; S Choudhary
Journal:  Indian J Pediatr       Date:  1989 Nov-Dec       Impact factor: 1.967

Review 2.  Cytomegaloviral virus infection in bone marrow transplantation recipients: strategies for prevention and treatment.

Authors:  H K Holland; R Saral
Journal:  Support Care Cancer       Date:  1993-09       Impact factor: 3.603

Review 3.  Viral skin infections in the elderly: diagnosis and management.

Authors:  Rashmi Bansal; William D Tutrone; Jeffrey M Weinberg
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

4.  Recognition of Dual or Multiple Pathology in Skin Biopsies from Patients with HIV/AIDS.

Authors:  Wayne Grayson
Journal:  Patholog Res Int       Date:  2011-06-22

5.  Improved detection of HSV by electron microscopy in clinical specimens using ultracentrifugation and colloidal gold immunoelectron microscopy: comparison with viral culture and cytodiagnosis.

Authors:  E Folkers; J Vreeswijk; A P Oranje; F Wagenaar; J N Duivenvoorden
Journal:  J Virol Methods       Date:  1991-10       Impact factor: 2.014

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.